首页 > 最新文献

Drug and Therapeutics Bulletin最新文献

英文 中文
When it comes to drugs, sex matters. 当涉及到毒品时,性很重要。
Q4 Medicine Pub Date : 2024-11-28 DOI: 10.1136/dtb.2024.000024
{"title":"When it comes to drugs, sex matters.","authors":"","doi":"10.1136/dtb.2024.000024","DOIUrl":"10.1136/dtb.2024.000024","url":null,"abstract":"","PeriodicalId":11277,"journal":{"name":"Drug and Therapeutics Bulletin","volume":"62 12","pages":"178"},"PeriodicalIF":0.0,"publicationDate":"2024-11-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142750313","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Does menopause hormone therapy prevent Alzheimer's disease and dementia? 更年期激素治疗能预防阿尔茨海默病和痴呆吗?
Q4 Medicine Pub Date : 2024-11-28 DOI: 10.1136/dtb.2024.000041
Barbara Mintzes, Adriane Fugh-Berman

Commentary on: Nerattini M, Jett S, Andy C, et al Systematic review and meta-analysis of the effects of menopause hormone therapy on risk of Alzheimer's disease and dementia. Front Aging Neurosci. 2023;15:1260427. Series Editor: Dr Teck Khong, DTB Associate Editor, Clinical Pharmacology, St George's,University of London, UK.

评论:Nerattini M, Jett S, Andy C,等。绝经期激素治疗对阿尔茨海默病和痴呆风险影响的系统回顾和荟萃分析。前沿衰老神经科学[j]; 2009;15:1260427。系列编辑:Dr Teck Khong, DTB副编辑,临床药理学,圣乔治,英国伦敦大学。
{"title":"Does menopause hormone therapy prevent Alzheimer's disease and dementia?","authors":"Barbara Mintzes, Adriane Fugh-Berman","doi":"10.1136/dtb.2024.000041","DOIUrl":"10.1136/dtb.2024.000041","url":null,"abstract":"<p><p><b>Commentary on:</b> Nerattini M, Jett S, Andy C, <i>et al</i> Systematic review and meta-analysis of the effects of menopause hormone therapy on risk of Alzheimer's disease and dementia. Front Aging Neurosci. 2023;15:1260427. <b>Series Editor:</b> Dr Teck Khong, DTB Associate Editor, Clinical Pharmacology, St George's,University of London, UK.</p>","PeriodicalId":11277,"journal":{"name":"Drug and Therapeutics Bulletin","volume":"62 12","pages":"179-182"},"PeriodicalIF":0.0,"publicationDate":"2024-11-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142750307","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Delayed drug-induced liver injury (DILI) and flare of chronic plaque psoriasis secondary to lisinopril use. 继发于使用利辛普利的药物性肝损伤(DILI)和慢性斑块状银屑病复发。
Q4 Medicine Pub Date : 2024-11-28 DOI: 10.1136/dtb.2024.256317rep
Georgeina L Jarman, Gwilym J Webb
{"title":"Delayed drug-induced liver injury (DILI) and flare of chronic plaque psoriasis secondary to lisinopril use.","authors":"Georgeina L Jarman, Gwilym J Webb","doi":"10.1136/dtb.2024.256317rep","DOIUrl":"10.1136/dtb.2024.256317rep","url":null,"abstract":"","PeriodicalId":11277,"journal":{"name":"Drug and Therapeutics Bulletin","volume":" ","pages":"189-191"},"PeriodicalIF":0.0,"publicationDate":"2024-11-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142496967","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Bleeding risk with oral anticoagulant plus SSRI. 口服抗凝剂加 SSRI 的出血风险。
Q4 Medicine Pub Date : 2024-10-29 DOI: 10.1136/dtb.2024.000061

Overview of: Rahman AA, Platt RW, Beradid S, et al. Concomitant use of selective serotonin reuptake inhibitors with oral anticoagulants and risk of major bleeding. JAMA Netw Open. 2024;7:e243208.

概述:Rahman AA、Platt RW、Beradid S 等. 选择性 5-羟色胺再摄取抑制剂与口服抗凝剂的同时使用及大出血风险。JAMA Netw Open.2024;7:e243208.
{"title":"Bleeding risk with oral anticoagulant plus SSRI.","authors":"","doi":"10.1136/dtb.2024.000061","DOIUrl":"10.1136/dtb.2024.000061","url":null,"abstract":"<p><p><b>Overview of:</b> Rahman AA, Platt RW, Beradid S, et al. Concomitant use of selective serotonin reuptake inhibitors with oral anticoagulants and risk of major bleeding. <i>JAMA Netw Open.</i> 2024;7:e243208.</p>","PeriodicalId":11277,"journal":{"name":"Drug and Therapeutics Bulletin","volume":" ","pages":"164"},"PeriodicalIF":0.0,"publicationDate":"2024-10-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142399690","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Supporting the treatment of obesity. 支持治疗肥胖症。
Q4 Medicine Pub Date : 2024-10-29 DOI: 10.1136/dtb.2024.000053
David Phizackerley
{"title":"Supporting the treatment of obesity.","authors":"David Phizackerley","doi":"10.1136/dtb.2024.000053","DOIUrl":"10.1136/dtb.2024.000053","url":null,"abstract":"","PeriodicalId":11277,"journal":{"name":"Drug and Therapeutics Bulletin","volume":" ","pages":"162"},"PeriodicalIF":0.0,"publicationDate":"2024-10-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142145384","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Angioedema without urticaria after recent initiation of celecoxib. 近期开始服用塞来昔布后出现血管性水肿,但无荨麻疹。
Q4 Medicine Pub Date : 2024-10-29 DOI: 10.1136/dtb.2024.e255446rep
Vivek Vardhan Jasti, Jay Anderson, Ifa Abdujelil
{"title":"Angioedema without urticaria after recent initiation of celecoxib.","authors":"Vivek Vardhan Jasti, Jay Anderson, Ifa Abdujelil","doi":"10.1136/dtb.2024.e255446rep","DOIUrl":"10.1136/dtb.2024.e255446rep","url":null,"abstract":"","PeriodicalId":11277,"journal":{"name":"Drug and Therapeutics Bulletin","volume":" ","pages":"173-175"},"PeriodicalIF":0.0,"publicationDate":"2024-10-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141283255","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pharma funding of patient organisations. 制药公司资助患者组织。
Q4 Medicine Pub Date : 2024-10-29 DOI: 10.1136/dtb.2024.000060

Overview of: Gentilini A, Parvanova I. Industry funding of patient organisations in the UK: a retrospective study of commercial determinants, funding concentration and disease prevalence. BMJ Open. 2023;13:e071138.

概述:Gentilini A, Parvanova I. 英国患者组织的行业资助:关于商业决定因素、资助集中度和疾病流行的回顾性研究。BMJ Open.2023;13:e071138.
{"title":"Pharma funding of patient organisations.","authors":"","doi":"10.1136/dtb.2024.000060","DOIUrl":"10.1136/dtb.2024.000060","url":null,"abstract":"<p><p><b>Overview of:</b> Gentilini A, Parvanova I. Industry funding of patient organisations in the UK: a retrospective study of commercial determinants, funding concentration and disease prevalence. <i>BMJ Open.</i> 2023;13:e071138.</p>","PeriodicalId":11277,"journal":{"name":"Drug and Therapeutics Bulletin","volume":" ","pages":"163"},"PeriodicalIF":0.0,"publicationDate":"2024-10-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142399691","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Best practice in COPD care: a health equity approach. 慢性阻塞性肺病护理的最佳实践:健康公平方法。
Q4 Medicine Pub Date : 2024-10-29 DOI: 10.1136/dtb.2023.000067
Anna Moore, Hannah Hylton, Alex Long, Catherine Taylor, Patricia Pennington, Irem Patel

There is a strong evidence base for the best care in chronic obstructive pulmonary disease (COPD) as outlined by the National Institute for Health and Care Excellence in its five fundamentals of COPD care: offer treatment and support to stop smoking; offer pneumococcal and influenza vaccinations; offer pulmonary rehabilitation if indicated; codevelop a personalised self-management plan; and optimise treatment for comorbidities. However, only a minority of those living with COPD receive or engage with all five interventions, with clear implications for outcomes. Further, barriers which prevent people who live with COPD accessing necessary care are unequally experienced. In order to overcome many of these barriers, clinicians caring for people with COPD must prioritise personalised treatment and continuity of care.

美国国家健康与护理卓越研究所(National Institute for Health and Care Excellence)在其慢性阻塞性肺疾病(COPD)护理的五项基本原则中概述了慢性阻塞性肺疾病(COPD)的最佳护理方法,并提出了强有力的证据基础:提供戒烟治疗和支持;提供肺炎球菌疫苗和流感疫苗接种;在有指征的情况下提供肺康复治疗;制定个性化的自我管理计划;以及优化合并症的治疗。然而,只有少数慢性阻塞性肺病患者接受或参与了所有五项干预措施,这对治疗效果有着明显的影响。此外,阻碍慢性阻塞性肺病患者获得必要护理的障碍也不尽相同。为了克服这些障碍,护理慢性阻塞性肺病患者的临床医生必须优先考虑个性化治疗和持续护理。
{"title":"Best practice in COPD care: a health equity approach.","authors":"Anna Moore, Hannah Hylton, Alex Long, Catherine Taylor, Patricia Pennington, Irem Patel","doi":"10.1136/dtb.2023.000067","DOIUrl":"https://doi.org/10.1136/dtb.2023.000067","url":null,"abstract":"<p><p>There is a strong evidence base for the best care in chronic obstructive pulmonary disease (COPD) as outlined by the National Institute for Health and Care Excellence in its five fundamentals of COPD care: offer treatment and support to stop smoking; offer pneumococcal and influenza vaccinations; offer pulmonary rehabilitation if indicated; codevelop a personalised self-management plan; and optimise treatment for comorbidities. However, only a minority of those living with COPD receive or engage with all five interventions, with clear implications for outcomes. Further, barriers which prevent people who live with COPD accessing necessary care are unequally experienced. In order to overcome many of these barriers, clinicians caring for people with COPD must prioritise personalised treatment and continuity of care.</p>","PeriodicalId":11277,"journal":{"name":"Drug and Therapeutics Bulletin","volume":"62 11","pages":"165-172"},"PeriodicalIF":0.0,"publicationDate":"2024-10-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142544248","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Intravenous vitamin C for COVID-19: no benefit. 静脉注射维生素 C 治疗 COVID-19:无益。
Q4 Medicine Pub Date : 2024-09-25 DOI: 10.1136/dtb.2024.000055

Overview of: LOVIT-COVID Investigators. Intravenous vitamin C for patients hospitalized with COVID-19: two harmonized randomized clinical trials. JAMA 2023;330:1745-59.

概述:LOVIT-COVID 研究者。为COVID-19住院患者静脉注射维生素C:两项统一随机临床试验。JAMA 2023;330:1745-59.
{"title":"Intravenous vitamin C for COVID-19: no benefit.","authors":"","doi":"10.1136/dtb.2024.000055","DOIUrl":"https://doi.org/10.1136/dtb.2024.000055","url":null,"abstract":"<p><p><b>Overview of:</b> LOVIT-COVID Investigators. Intravenous vitamin C for patients hospitalized with COVID-19: two harmonized randomized clinical trials. <i>JAMA</i> 2023;330:1745-59.</p>","PeriodicalId":11277,"journal":{"name":"Drug and Therapeutics Bulletin","volume":"62 10","pages":"148"},"PeriodicalIF":0.0,"publicationDate":"2024-09-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142336337","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
(Un)common sense in oncology. (肿瘤学中的(非)常识。
Q4 Medicine Pub Date : 2024-09-25 DOI: 10.1136/dtb.2024.000043
Adrian M J Pokorny
{"title":"(Un)common sense in oncology.","authors":"Adrian M J Pokorny","doi":"10.1136/dtb.2024.000043","DOIUrl":"10.1136/dtb.2024.000043","url":null,"abstract":"","PeriodicalId":11277,"journal":{"name":"Drug and Therapeutics Bulletin","volume":" ","pages":"146"},"PeriodicalIF":0.0,"publicationDate":"2024-09-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142145383","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Drug and Therapeutics Bulletin
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1